Likewise, PBMCs from patients with primary progressive MS (PPMS) overexpress pro-inflammatory cytokines, including IL-1β, IL-6, TNF, and NLRP3, with monocytes being the primary driver of this profile [41]. This evidence concerns the gene IL1B and primary progressive multiple sclerosis.